Home › Free Stock Grades › LBRX
LB Pharmaceuticals Inc Common Stock (LBRX) Stock Grade
LBRX · Healthcare
C
Market Cap
$1.1B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About LB Pharmaceuticals Inc Common Stock's fundamentals
LB Pharmaceuticals is a biotechnology company with a market capitalization of $1.1 billion that reported zero year-over-year revenue growth and a net loss in its latest annual statement, resulting in a net margin of 0.0%. The company does not pay a dividend and lacks meaningful profitability metrics. As a loss-making biotech firm, the company's financial performance is currently characterized by flat revenues and negative earnings rather than traditional profitability indicators.